DPT / Dermatopontin · Western blot design guide

Design a Western Blot for DPT

Real validated DPT Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DPT WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for DPT: expected band ~24 kDa, hero antibody A02642-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable DPT Western blot protocol sheet — expected band ~24 kDa, antibody A02642-1, controls and PMC citations. Open the full DPT WB guide →

DPT Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~24 kDa
Observed band ~20 kDa
Gel 5–20% (catalog A02642-1)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Cleaved
Caveat Secreted ECM protein
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated DPT Western Blot Protocols

The A02642-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Hela, human placenta, rat lung (catalog A02642-1)
Gel %5–20% (catalog A02642-1)
Load50ug; reducing conditions (catalog A02642-1)
Transfera Nitrocellulose membrane at 150mA for 50-90 minutes (catalog A02642-1)
MembraneNitrocellulose membrane (catalog A02642-1)
Blocking5% Non-fat Milk/ TBS for 1.5 hour at RT (catalog A02642-1)
Primary antibodyA02642-1 · 0.5 μg/mL (catalog A02642-1)
Primary incubationovernight at 4°C (catalog A02642-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:10000 (catalog A02642-1)
Secondary incubation1.5 hour at RT (catalog A02642-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A02642-1)
DetectionECL (catalog A02642-1)
Section 2

What Is the Expected DPT Western Blot Band Size?

DPT is predicted at 24 kDa and observed at ~20 kDa; the cause of the difference is not established.

What am I looking at on my blot?
Band at ~20 kDaEmpirical DPT band in reducing tissue and cell lysates; its lower migration than predicted is unexplained.
Band near 24 kDaCompatible with the predicted precursor mass; confirm identity with antibody controls.
Band below the precursor positionCould reflect signal-peptide removal, but a specific mature mass is not established.
Little or no band in whole-cell lysateDPT is secreted into the extracellular matrix.
💡Expected DPT appearanceDPT has a predicted precursor mass of 24 kDa, while antibody QC shows a band at ~20 kDa; the cause of the difference is unestablished, so confirm band identity with appropriate controls.
How each factor affects band size
Predicted precursor massProvides a 24 kDa sequence-based reference, not the measured band position.
Signal peptide at residues 1–18Cleavage can make mature DPT smaller than its precursor; mature migration is not supplied.
Pyrrolidone carboxylic acid at residue 19Its effect on apparent band size is not established.
Sulfotyrosines at residues 23, 162, 164, 166, 167, and 194Their effect on apparent band size is not established.
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateSecreted DPT may be depleted from whole-cell lysate.Check extracellular matrix or conditioned-medium samples alongside a positive control.
Band lower than expectedThe observed ~20 kDa band is below the 24 kDa precursor prediction; its cause is unestablished.Compare with a positive-control sample and confirm antibody specificity.
Band higher than expectedAn unidentified band may be nonspecific or have altered migration.Compare with a positive control and use an independent DPT antibody.
Multiple bandsPrecursor and signal-cleaved DPT are possible, but distinct bands are not established.Check sample preparation and compare bands using an independent DPT antibody.
Weak or no signalSecreted DPT may be scarce in the sampled fraction.Enrich extracellular material and include a positive-control sample.

Sample controls for DPT Western blot

🧪For positive controls for DPT in Western blot, you can use conditioned medium from a confirmed DPT-positive sample, although the supplied HPA data identify none.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: DPT is secreted, so conditioned medium may be more suitable than whole-cell lysate; the supplied HPA data provide no tissue controls.

HPA tissue expression evidence for DPT

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced DPT Western Blot Tips

Deeper troubleshooting and optimisation questions for DPT, answered from its protein features.

How should DPT band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could DPT isoforms explain multiple bands?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no isoform-based explanation for multiple bands. Compare any extra bands with the expected near-20 kDa signal and verify their identity experimentally.
Which DPT modifications should I consider when interpreting a band?
PTM · UniProt lists pyrrolidone carboxylic acid at residue 19 and sulfotyrosines at residues 23, 162, 164, 166, 167, and 194. It lists no glycosylation sites. These annotations alone do not demonstrate a visible band shift or explain the observed 20 kDa band.
Does this guide establish induction of DPT?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for DPT?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02642-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should DPT be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Why might DPT appear near 20 kDa instead of its predicted 24 kDa?
Interpretation · DPT has a predicted 24 kDa mass and an observed band near 20 kDa. Its signal peptide spans residues 1–18, so secretion involves removal of part of the predicted sequence. This may contribute to the difference, but the supplied features do not establish the band’s exact identity or explain its full apparent mass.

The signal peptide spans UniProt residues 1–18. Residue 19 is annotated as pyrrolidone carboxylic acid, consistent with modification at the start of the processed protein. These are UniProt coordinates; check the numbering convention used by an antibody or paper before comparing sites.

DPT is annotated as secreted into the extracellular space and extracellular matrix. Include the relevant extracellular or matrix-containing material in the sampling plan, and compare like fractions across conditions. A weak cellular-lysate signal alone would not establish low DPT abundance overall.

Use the same sample fraction and extraction procedure across conditions because DPT is secreted and associated with the extracellular matrix. Compare signals within the assay’s linear range and normalize to an appropriate measure of the material loaded from that fraction.

DPT has five annotated disulfide bonds and interacts with TGFB1, DCN, and collagen. Compare reducing and nonreducing preparations and check whether sample fractions differ in extracellular-matrix content. Those features suggest useful checks, but they do not identify an unexpected band or prove that a particular complex survives electrophoresis.
Boster reagents

DPT Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Dermatopontin using anti-Dermatopontin antibody (A02642-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human placenta tissue lysates, Lane 3: rat lung tissue lysates, Lane 4: mouse lung tissue lysates. After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Dermatopontin antigen affinity purified polyclonal antibody (Catalog # A02642-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Dermatopontin at approximately 20KD. The expected band size for Dermatopontin is at 24KD.
Anti-Dermatopontin/DPT Antibody Picoband®
Cat # A02642-1

The catalog reports one anti-DPT antibody, A02642-1, with stated human, mouse, and rat reactivity. Its Western blot image shows a band near 20 kDa versus the expected 24 kDa; the supplied evidence does not establish orthogonal validation.

Which to pick: A02642-1 is the only listed option and has a Western blot image using human HeLa cells and placenta, rat lung, and mouse lung lysates. The caption reports reducing conditions, 50 µg per lane, and 0.5 µg/mL primary antibody.

Source: BosterBio DPT gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.